According to today's presentation, the XanADu results didn't show efficacy because:
* endpoints not sufficiently sensitive
* trial duration too short.
The "not true Alzheimers" factor from the Spark Plus presentation wasn't mentioned.
Ann: Actinogen to present at ********* Small Cap Webinar, page-2
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.5¢ |
Change
-0.001(3.85%) |
Mkt cap ! $80.14M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.7¢ | 2.5¢ | $83.82K | 3.202M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 1220105 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 768793 | 4 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| ACW (ASX) Chart |